ArticleEuropean urology2023

Re: Dose-escalated Radiotherapy Alone or in Combination with Short-term Androgen Deprivation for Intermediate-risk Prostate Cancer: Results of a Phase III Multi-institutional Trial.

Angela Y Jia et al.PubMed ↗Publisher ↗

No numbers read from the abstract.